What is NMTC's current stock price?

NMTC (NeuroOne Medical Technologies Corporation) is currently trading at $3.69 with a market cap of $31.8M.

What sector is NeuroOne Medical Technologies Corporation in?

NeuroOne Medical Technologies Corporation (NMTC) operates in the Healthcare sector, specifically in the Medical - Devices industry.

Is NMTC a good stock to buy?

Analysts have a Buy consensus on NMTC with a price target of $3.00. Check our detailed analysis for valuation, financials, and insider activity.

InvestLog

NMTC NeuroOne Medical Technologies Corporation

Healthcare

$3.69-5.38%ClosedMarket Cap: $31.8M

As of 2026-05-25

Valuation

View Details

P/E (TTM)

—

PEG

—

P/B

5.79

P/S

3.27

EV/EBITDA

-4.38

DCF Value

$-286.62

FCF Yield

-23.8%

Div Yield

0.0%

Margins & Returns

Gross Margin

54.5%

Operating Margin

-72.7%

Net Margin

-68.3%

ROE

-98.3%

ROA

-84.5%

ROIC

-112.3%

Financials

View All

Period	Revenue	Net Income	EPS
Q2 null	$2.4M	$-2.1M	$—
Q1 null	$2.9M	$-1.4M	$—
Q4 null	$2.7M	$-1.6M	$—
FY null	$12.1M	$-3.6M	$—

Analyst Ratings

View All

Consensus

Buy

Target (Consensus)

$3.00

Target (Median)

$3.00

Target Range

$3.00 - $3.00

1 Strong Buy2 Buy0 Hold0 Sell0 Strong Sell

Ladenburg ThalmannBuy

2026-05-13

Trading Activity

Insider Trades

View All

Mills Jason Richarddirector

SellTue Apr 07

Mills Jason Richarddirector

SellTue Apr 07

MATHIESEN JEFFREY Sdirector

SellTue Apr 07

MATHIESEN JEFFREY Sdirector

SellTue Apr 07

BUCKMAN PAULdirector

SellTue Apr 07

Company Info

Sector

Healthcare

Industry

Medical - Devices

Country

Exchange

—

Beta

0.58

NeuroOne Medical Technologies Corporation operates as a medical technology company. The company focuses on the development and commercialization of thin film electrode technology for continuous electroencephalogram (cEEG) and stereoelectroencephalography (sEEG) recording, spinal cord stimulation, brain stimulation, and ablation solutions for patients suffering from epilepsy, Parkinson's disease, dystonia, essential tremors, chronic pain due to failed back surgeries, and other related neurological disorders. It has a strategic partnership with RBC Medical Innovations to develop a radio frequency ablation generator for use with NeuroOne's combination recording and ablation electrode to record brain activity and ablate brain tissue using the same electrode. The company is based in Eden Prairie, Minnesota.

Peers

MYO